Kurs & Likviditet
Kalender
| 2024-08-14 | Kvartalsrapport 2024-Q2 |
| 2024-03-07 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2024-03-06 | Årsstämma |
| 2024-02-06 | Bokslutskommuniké 2023 |
| 2023-08-15 | Kvartalsrapport 2023-Q2 |
| 2023-03-09 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2023-03-08 | Årsstämma |
| 2023-02-07 | Bokslutskommuniké 2022 |
| 2022-08-16 | Kvartalsrapport 2022-Q2 |
| 2022-03-11 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2022-03-10 | Årsstämma |
| 2022-02-08 | Bokslutskommuniké 2021 |
| 2021-08-12 | Kvartalsrapport 2021-Q2 |
| 2021-03-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2021-03-05 | Årsstämma |
| 2021-02-09 | Bokslutskommuniké 2020 |
| 2020-08-17 | Kvartalsrapport 2020-Q2 |
| 2020-03-11 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2020-03-10 | Årsstämma |
| 2020-02-04 | Bokslutskommuniké 2019 |
| 2019-08-14 | Kvartalsrapport 2019-Q2 |
| 2019-03-20 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2019-03-19 | Årsstämma |
| 2019-02-19 | Bokslutskommuniké 2018 |
| 2018-08-15 | Kvartalsrapport 2018-Q2 |
| 2018-03-23 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2018-03-22 | Årsstämma |
| 2018-02-22 | Bokslutskommuniké 2017 |
| 2017-08-14 | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | Kvartalsrapport 2017-Q1 |
| 2017-03-28 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2017-03-27 | Årsstämma |
| 2017-02-23 | Bokslutskommuniké 2016 |
| 2016-11-10 | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | Kvartalsrapport 2016-Q2 |
| 2016-05-25 | Split DEMANT 1:5 |
| 2016-05-10 | Kvartalsrapport 2016-Q1 |
| 2016-04-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2016-04-07 | Årsstämma |
| 2016-03-01 | Bokslutskommuniké 2015 |
| 2015-11-12 | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | Kvartalsrapport 2015-Q1 |
| 2015-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2015-04-09 | Årsstämma |
| 2015-02-26 | Bokslutskommuniké 2014 |
| 2014-11-13 | Kvartalsrapport 2014-Q3 |
| 2014-08-14 | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2014-04-09 | Årsstämma |
| 2014-02-27 | Bokslutskommuniké 2013 |
| 2013-11-05 | Kvartalsrapport 2013-Q3 |
| 2013-08-14 | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | Kvartalsrapport 2013-Q1 |
| 2013-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2013-04-09 | Årsstämma |
| 2013-02-26 | Bokslutskommuniké 2012 |
| 2012-11-07 | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2012-04-11 | Årsstämma |
| 2012-02-29 | Bokslutskommuniké 2011 |
| 2011-11-10 | Kvartalsrapport 2011-Q3 |
| 2011-08-19 | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2011-04-13 | Årsstämma |
| 2010-11-16 | Kvartalsrapport 2010-Q3 |
| 2010-04-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
17.4.2023 14:58:18 CEST | Demant A/S | Total number of voting rights and capital
Company announcement no 2023-05 | 17 April 2023 |
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2023-04, it was decided at Demant A/S’ ordinary general meeting on 8 March 2023 to reduce the company’s share capital by nominally DKK 1,287,859.00 divided into 6,439,295 shares of DKK 0.20, corresponding to the company’s holding of treasury shares at 15 January 2023 less shares to cover Management’s retention programme and the share salary arrangement offered
to employees.
The capital reduction was published via the electronic information system of the Danish Business Authority on 16 March 2023. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 44,787,888.00.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 44,787,888.00
Number of voting rights: 223,939,440
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Trine Kromann-Mikkelsen, VP Corporate Communications and Sustainability |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.